The Pharmaceutical Journal,
November 04, 2000

Back issues

Return to PJ Online Home Page

Comment

News

Clinical

Conference

The Society

Notice Board

Products

Comment

An Onlooker's Notebook   670

Leading Articles   671

News   672-674

Clinical Pharmacy   675-677

The Society   678

Broad Spectrum   679

Letters to the Editor   680-683

News Feature   684-685

Articles   686-691

Conference   692-696

Forum   697-700

Products   701

Notice-Board   702

Front Cover Picture

Our front cover photograph of a veterinary consultation ties in with our reports this week from meetings of the Royal Pharmaceutical Society’s Veterinary Pharmacists Group and the British Veterinary Association. Both meetings devoted time to discussions of the Government-ordered independent review of the precribing of veterinary medicines. Forum (pp697-700). Leading article (p671).

Methylphenidate guidance

The National Institute for Clinical Excellence has issued guidance on the prescribing of methylphenidate for children with severe attention deficit/hyperactivity disorder (p675).

Viral diseases

Issues in viral diseases is the subject of a news feature beginning on p684.

Generic pricing

The implications for primary care of the House of Commons health select committee’s report on generic prescribing are discussed in an article by economists from Glamorgan and Birmingham (p689).

Antibiotic resistance

The global threat of antibiotic resistance was the subject of a microbiology symposium at the British Pharmaceutical Conference recently (p692).

Click here for this month's Hospital Pharmacist